217 related articles for article (PubMed ID: 33002549)
1. The effect of COVID-19 on Ramadan fasting in people with diabetes in East London 2020: The East London diabetes in Ramadan survey.
Khan H; Chowdhury A; Lasker SS; Chowdhury TA
Diabetes Res Clin Pract; 2020 Nov; 169():108476. PubMed ID: 33002549
[TBL] [Abstract][Full Text] [Related]
2. Fasting outcomes in people with diabetes and chronic kidney disease in East London during Ramadan 2018: The East London diabetes in Ramadan survey.
Chowdhury A; Khan H; Lasker SS; Chowdhury TA
Diabetes Res Clin Pract; 2019 Jun; 152():166-170. PubMed ID: 31150726
[TBL] [Abstract][Full Text] [Related]
3. Ramadan fasting in people with diabetes and chronic kidney disease (CKD) during the COVID-19 pandemic: The DaR global survey.
Hassanein M; Yousuf S; Ahmedani MY; Albashier A; Shaltout I; Yong A; Hafidh K; Hussein Z; Kallash MA; Aljohani N; Wong HC; Buyukbese MA; Chowdhury T; Fadhila MERZOUKI; Taher SW; Belkhadir J; Malek R; Abdullah NRA; Shaikh S; Alabbood M
Diabetes Metab Syndr; 2023 Jul; 17(7):102799. PubMed ID: 37301008
[TBL] [Abstract][Full Text] [Related]
4. Ramadan fasting in people with type 1 diabetes during COVID-19 pandemic: The DaR Global survey.
Hassanein M; Alamoudi RM; Kallash MA; Aljohani NJ; Alfadhli EM; Tony LE; Khogeer GS; Alfadhly AF; Khater AE; Ahmedani MY; Buyukbese MA; Shaltout I; Belkhadir J; Hafidh K; Chowdhury TA; Hussein Z; Elbarbary NS
Diabetes Res Clin Pract; 2021 Feb; 172():108626. PubMed ID: 33321160
[TBL] [Abstract][Full Text] [Related]
5. The DAR 2020 Global survey: Ramadan fasting during COVID 19 pandemic and the impact of older age on fasting among adults with Type 2 diabetes.
Hassanein M; Hussein Z; Shaltout I; Wan Seman WJ; Tong CV; Mohd Noor N; Buyukbese MA; El Tony L; Shaker GM; Alamoudi RM; Hafidh K; Fariduddin M; Batais MA; Shaikh S; Malek PR; Alabbood M; Sahay R; Alshenqete AM; Yakoob Ahmedani M
Diabetes Res Clin Pract; 2021 Mar; 173():108674. PubMed ID: 33493579
[TBL] [Abstract][Full Text] [Related]
6. Attitude and safety of patients with diabetes observing the Ramadan fast.
Ba-Essa EM; Hassanein M; Abdulrhman S; Alkhalifa M; Alsafar Z
Diabetes Res Clin Pract; 2019 Jun; 152():177-182. PubMed ID: 30946851
[TBL] [Abstract][Full Text] [Related]
7. Managing People with Diabetes Fasting for Ramadan During the COVID-19 Pandemic: A South Asian Health Foundation Update.
Hanif S; Ali SN; Hassanein M; Khunti K; Hanif W
Diabet Med; 2020 Jul; 37(7):1094-1102. PubMed ID: 32333691
[TBL] [Abstract][Full Text] [Related]
8. Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS).
Hassanein M; Echtay A; Hassoun A; Alarouj M; Afandi B; Poladian R; Bennakhi A; Nazar M; Bergmans P; Keim S; Hamilton G; Azar ST
Int J Clin Pract; 2017 Oct; 71(10):. PubMed ID: 28851109
[TBL] [Abstract][Full Text] [Related]
9. Higher HbA1c was observed in young people with diabetes who fasted during COVID-19 pandemic lockdown of 2020 Ramadan in Bangladesh - A Post Ramadan survey.
Zabeen B; Ahmed B; Nahar J; Tayyeb S; Islam N; Mohsin F; Azad K
Diabetes Res Clin Pract; 2022 Apr; 186():109812. PubMed ID: 35301071
[TBL] [Abstract][Full Text] [Related]
10. Knowledge of diabetes mellitus and safe practices during Ramadan fasting among Muslim patients with diabetes mellitus in Singapore.
Zainudin SB; Ang DY; Soh AW
Singapore Med J; 2017 May; 58(5):246-252. PubMed ID: 27121922
[TBL] [Abstract][Full Text] [Related]
11. Patient perspectives on type 2 diabetes and medicine use during Ramadan among Pakistanis in Denmark.
Mygind A; Kristiansen M; Wittrup I; Nørgaard LS
Int J Clin Pharm; 2013 Apr; 35(2):281-8. PubMed ID: 23354808
[TBL] [Abstract][Full Text] [Related]
12. Patterns of Diabetes Care Among People with Type 1 Diabetes During Ramadan: An International Prospective Study (DAR-MENA T1DM).
Al Awadi FF; Echtay A; Al Arouj M; Sabir Ali S; Shehadeh N; Al Shaikh A; Djaballah K; Dessapt-Baradez C; Omar Abu-Hijleh M; Bennakhi A; El Hassan Gharbi M; El Sayed El Hadidy K; Abdul Kareem Khazaal F; Hassanein MM
Adv Ther; 2020 Apr; 37(4):1550-1563. PubMed ID: 32144714
[TBL] [Abstract][Full Text] [Related]
13. The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial.
Al Sifri S; Basiounny A; Echtay A; Al Omari M; Harman-Boehm I; Kaddaha G; Al Tayeb K; Mahfouz AS; Al Elq A; Radican L; Ozesen C; Katzeff HL; Musser BJ; Suryawanshi S; Girman CJ; Davies MJ; Engel SS;
Int J Clin Pract; 2011 Nov; 65(11):1132-40. PubMed ID: 21951832
[TBL] [Abstract][Full Text] [Related]
14. Verification of 2021 IDF-DAR risk assessment tool for fasting Ramadan in patients with diabetes attending primary health care in The Kingdom of Bahrain: The DAR-BAH study.
Shamsi N; Naser J; Humaidan H; Al-Saweer A; Jaafar M; Abbas F; Al-Doseri S; Shabeeb N; Al-Shaikh E; Al-Dairi A; Mandoos K
Diabetes Res Clin Pract; 2024 May; 211():111661. PubMed ID: 38604445
[TBL] [Abstract][Full Text] [Related]
15. Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study.
Aravind SR; Ismail SB; Balamurugan R; Gupta JB; Wadhwa T; Loh SM; Suryawanshi S; Davies MJ; Girman CJ; Katzeff HL; Radican L; Engel SS; Wolthers T
Curr Med Res Opin; 2012 Aug; 28(8):1289-96. PubMed ID: 22738801
[TBL] [Abstract][Full Text] [Related]
16. A survey of fasting practices and acceptance of an intervention for achieving control in diabetes during Ramadan.
Dabral S; Mukherjee S; Saha N; Manjavkar S; Kohli S
Natl Med J India; 2020; 33(1):5-9. PubMed ID: 33565478
[TBL] [Abstract][Full Text] [Related]
17. CREED study: Hypoglycaemia during Ramadan in individuals with Type 2 diabetes mellitus from three continents.
Jabbar A; Hassanein M; Beshyah SA; Boye KS; Yu M; Babineaux SM
Diabetes Res Clin Pract; 2017 Oct; 132():19-26. PubMed ID: 28783529
[TBL] [Abstract][Full Text] [Related]
18. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study.
Salti I; Bénard E; Detournay B; Bianchi-Biscay M; Le Brigand C; Voinet C; Jabbar A;
Diabetes Care; 2004 Oct; 27(10):2306-11. PubMed ID: 15451892
[TBL] [Abstract][Full Text] [Related]
19. Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes who fast during Ramadan: The observational ORION study.
Hassanein M; Buyukbese MA; Malek R; Pilorget V; Naqvi M; Berthou B; Shaltout I; Kumar Sahay R
Diabetes Res Clin Pract; 2020 Aug; 166():108189. PubMed ID: 32360709
[TBL] [Abstract][Full Text] [Related]
20. Optimizing Ramadan fasting: A randomised controlled trial for people with type 2 diabetes during Ramadan applying the principles of the ADA/EASD consensus.
Ibrahim M; Barker MM; Ahmad E; Ahmed A; Annabi FA; Ba-Essa EM; Davies MJ; Houeiss P; Iraqi H; Masood SN; Mimouni-Zerguini S; Shaikh S; Tantawi H; Tuomilehto J
Diabetes Metab Res Rev; 2023 Mar; 39(3):e3604. PubMed ID: 36547366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
